Search Results

There are 4977 results for: content related to: New paradigms for the treatment of chronic hepatitis B

  1. You have free access to this content
    HBV Trials and Treatments

    Hepatology

    Volume 58, Issue S1, October 2013, Pages: 647A–705A,

    Version of Record online : 15 OCT 2013, DOI: 10.1002/hep.26856

  2. You have free access to this content
    JSH Guidelines for the Management of Hepatitis B Virus Infection

    Hepatology Research

    Volume 44, Issue S1, January 2014, Pages: 1–58, Drafting Committee for Hepatitis Management Guidelines and the Japan Society of Hepatology

    Version of Record online : 7 JAN 2014, DOI: 10.1111/hepr.12269

  3. You have free access to this content
    Poster Session IV (Abstracts 1638 – 2112)

    Hepatology

    Volume 64, Issue S1, October 2016, Pages: 811–1050,

    Version of Record online : 1 OCT 2016, DOI: 10.1002/hep.28800

  4. You have free access to this content
    Poster Session 4: Hepatitis B Therapy

    Hepatology

    Volume 60, Issue S1, October 2014, Pages: 1088A–1128A,

    Version of Record online : 1 OCT 2014, DOI: 10.1002/hep.27532

  5. You have free access to this content
    Chronic hepatitis B

    Hepatology

    Volume 45, Issue 2, February 2007, Pages: 507–539, Anna S. F. Lok and Brian J. McMahon

    Version of Record online : 26 JAN 2007, DOI: 10.1002/hep.21513

  6. Current antiviral therapies for chronic hepatitis B

    Hepatology Research

    Volume 38, Issue 6, June 2008, Pages: 535–542, Mari Inada and Osamu Yokosuka

    Version of Record online : 29 APR 2008, DOI: 10.1111/j.1872-034X.2008.00323.x

  7. You have free access to this content
    Review article: current antiviral therapy of chronic hepatitis B

    Alimentary Pharmacology & Therapeutics

    Volume 34, Issue 10, November 2011, Pages: 1145–1158, W. S. Ayoub and E. B. Keeffe

    Version of Record online : 7 OCT 2011, DOI: 10.1111/j.1365-2036.2011.04869.x

  8. You have free access to this content
    Undetectable HBV DNA at month 12 of entecavir treatment predicts maintained viral suppression and HBeAg-seroconversion in chronic hepatitis B patients at 3 years

    Alimentary Pharmacology & Therapeutics

    Volume 35, Issue 11, June 2012, Pages: 1326–1335, G. L.-H. Wong, V. W.-S. Wong, H.-Y. Chan, P. C.-H. Tse, J. Wong, A. M.-L. Chim, K. K.-L. Yiu, S. H.-T. Chu and H. L.-Y. Chan

    Version of Record online : 16 APR 2012, DOI: 10.1111/j.1365-2036.2012.05098.x

  9. You have free access to this content
    Treatment of HBeAg positive chronic hepatitis B: interferon or nucleoside analogues

    Liver International

    Volume 33, Issue s1, February 2013, Pages: 137–150, Geoffrey Dusheiko

    Version of Record online : 3 JAN 2013, DOI: 10.1111/liv.12078

  10. You have free access to this content
    Poster Presentations

    Journal of Gastroenterology and Hepatology

    Volume 28, Issue S3, October 2013, Pages: 23–693,

    Version of Record online : 17 SEP 2013, DOI: 10.1111/jgh.12363_2

  11. An early decrease in serum HBeAg titre is a strong predictor of virological response to entecavir in HBeAg-positive patients

    Journal of Viral Hepatitis

    Volume 18, Issue 7, July 2011, Pages: e184–e190, X. Zhang, S.-m. Lin, F. Ye, T.-y. Chen, M. Liu, Y.-r. Chen, S.-q. Zheng, Y.-r. Zhao and S.-l. Zhang

    Version of Record online : 13 JAN 2011, DOI: 10.1111/j.1365-2893.2010.01423.x

  12. You have free access to this content
    Randomized, controlled trial of entecavir versus placebo in children with hepatitis B envelope antigen–positive chronic hepatitis B

    Hepatology

    Volume 63, Issue 2, February 2016, Pages: 377–387, Maureen M. Jonas, Mei-Hwei Chang, Etienne Sokal, Kathleen B. Schwarz, Deirdre Kelly, Kyung Mo Kim, Simon C. Ling, Philip Rosenthal, Dumitru Oraseanu, Laurie Reynolds, Alexandra Thiry and Peter Ackerman

    Version of Record online : 16 OCT 2015, DOI: 10.1002/hep.28015

  13. You have free access to this content
    Entecavir treatment for up to 5 years in patients with hepatitis B e antigen–positive chronic hepatitis B

    Hepatology

    Volume 51, Issue 2, February 2010, Pages: 422–430, Ting-Tsung Chang, Ching-Lung Lai, Seung Kew Yoon, Samuel S. Lee, Henrique Sergio M. Coelho, Flair Jose Carrilho, Fred Poordad, Waldemar Halota, Yves Horsmans, Naoky Tsai, Hui Zhang, Daniel J. Tenney, Ricardo Tamez and Uchenna Iloeje

    Version of Record online : 4 JAN 2010, DOI: 10.1002/hep.23327

  14. You have full text access to this OnlineOpen article
    Safety and efficacy of two-step peginterferon α-2a treatment in patients of chronic hepatitis B with acute exacerbation

    Journal of Viral Hepatitis

    Volume 19, Issue 3, March 2012, Pages: 161–172, C.-C. Chen, P.-C. Wang, H.-W. Chang and C.-F. Chen

    Version of Record online : 4 JUL 2011, DOI: 10.1111/j.1365-2893.2011.01469.x

  15. You have free access to this content
    Virological, serological and biochemical outcomes through 3 years of entecavir treatment in nucleoside-naive Chinese chronic hepatitis B patients

    Journal of Viral Hepatitis

    Volume 17, Issue s1, March 2010, Pages: 51–58, G. B. Yao, H. Ren, D. Z. Xu, X. Q. Zhou, J. D. Jia, Y. M. Wang and C. W. Chen

    Version of Record online : 3 MAR 2010, DOI: 10.1111/j.1365-2893.2010.01271.x

  16. You have free access to this content
    A comparison of efficacy and safety of 2-year telbivudine and entecavir treatment in patients with chronic hepatitis B: a match–control study

    Clinical Microbiology and Infection

    Volume 20, Issue 2, February 2014, Pages: O90–O100, M.-C. Tsai, C.-H. Chen, C.-H. Hung, C.-M. Lee, K.-W. Chiu, J.-H. Wang, S.-N. Lu, P.-L. Tseng, K.-C. Chang, Y.-H. Yen and T.-H. Hu

    Version of Record online : 10 MAY 2013, DOI: 10.1111/1469-0691.12220

  17. You have free access to this content
    AASLD guidelines for treatment of chronic hepatitis B

    Hepatology

    Volume 63, Issue 1, January 2016, Pages: 261–283, Norah A. Terrault, Natalie H. Bzowej, Kyong-Mi Chang, Jessica P. Hwang, Maureen M. Jonas and M. Hassan Murad

    Version of Record online : 13 NOV 2015, DOI: 10.1002/hep.28156

  18. You have free access to this content
    Poster Sessions

    Hepatology

    Volume 58, Issue S1, October 2013, Pages: 92A–207A,

    Version of Record online : 1 OCT 2013, DOI: 10.1002/hep.26726

  19. Optimal duration of additional therapy after biochemical and virological responses to lamivudine in patients with HBeAg-negative chronic hepatitis B: a randomized trial

    Hepatology Research

    Volume 38, Issue 9, September 2008, Pages: 954–959, Masaru Enomoto, Akihiro Tamori, Madoka Toyama Kohmoto, Takehiro Hayashi, Hiroyasu Morikawa, Hisato Jomura, Hiroki Sakaguchi, Daiki Habu, Norifumi Kawada, Susumu Shiomi and Shuhei Nishiguchi

    Version of Record online : 21 MAY 2008, DOI: 10.1111/j.1872-034X.2008.00378.x

  20. You have free access to this content
    Poster Session 4: Stem Cell Biology; Varices and Bleeding

    Hepatology

    Volume 62, Issue S1, October 2015, Pages: 1195A–1215A,

    Version of Record online : 7 OCT 2015, DOI: 10.1002/hep.28243